These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 32217864)

  • 1. Effect of Antidepressants on Psychotic Symptoms in Parkinson Disease: A Review of Case Reports and Case Series.
    Sid-Otmane L; Huot P; Panisset M
    Clin Neuropharmacol; 2020; 43(3):61-65. PubMed ID: 32217864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology and treatment of psychosis in Parkinson's disease: a review.
    Zahodne LB; Fernandez HH
    Drugs Aging; 2008; 25(8):665-82. PubMed ID: 18665659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mirtazapine improves visual hallucinations in Parkinson's disease: a case report.
    Tagai K; Nagata T; Shinagawa S; Tsuno N; Ozone M; Nakayama K
    Psychogeriatrics; 2013 Jun; 13(2):103-7. PubMed ID: 23909968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressants in the treatment of psychosis with comorbid depression in Parkinson disease.
    Voon V; Lang AE
    Clin Neuropharmacol; 2004; 27(2):90-2. PubMed ID: 15252271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Meco G; Bernardi S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressants and the risk of hyponatremia: a Danish register-based population study.
    Leth-Møller KB; Hansen AH; Torstensson M; Andersen SE; Ødum L; Gislasson G; Torp-Pedersen C; Holm EA
    BMJ Open; 2016 May; 6(5):e011200. PubMed ID: 27194321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment options for depression and psychosis in Parkinson's disease.
    Poewe W; Seppi K
    J Neurol; 2001 Sep; 248 Suppl 3():III12-21. PubMed ID: 11697683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
    Tedeschini E; Levkovitz Y; Iovieno N; Ameral VE; Nelson JC; Papakostas GI
    J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of parkinsonism and psychosis with mirtazapine: a case report.
    Godschalx-Dekker JA; Siegers HP
    Pharmacopsychiatry; 2014 May; 47(3):81-3. PubMed ID: 24504487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
    Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
    Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
    Cipriani A; Zhou X; Del Giovane C; Hetrick SE; Qin B; Whittington C; Coghill D; Zhang Y; Hazell P; Leucht S; Cuijpers P; Pu J; Cohen D; Ravindran AV; Liu Y; Michael KD; Yang L; Liu L; Xie P
    Lancet; 2016 Aug; 388(10047):881-90. PubMed ID: 27289172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroencephalographic abnormalities associated with antidepressant treatment: a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline.
    Sterr A; Padberg F; Amann B; Mergl R; Mulert C; Juckel G; Hegerl U; Pogarell O
    J Clin Psychiatry; 2006 Feb; 67(2):325-6. PubMed ID: 16566633
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined treatment with aripiprazole and antidepressants reversed some MK-801-induced schizophrenia-like symptoms in mice.
    Rogóż Z; Wąsik A; Lorenc-Koci E
    Pharmacol Rep; 2018 Aug; 70(4):623-630. PubMed ID: 29885435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial.
    Duffy L; Bacon F; Clarke CS; Donkor Y; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Lewis G; Mangin D; Marston L; Moore M; Nazareth I; Wiles N; Lewis G
    Trials; 2019 Jun; 20(1):319. PubMed ID: 31159856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
    Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT
    Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New formulations of existing antidepressants: advantages in the management of depression.
    Norman TR; Olver JS
    CNS Drugs; 2004; 18(8):505-20. PubMed ID: 15182220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amoxapine shows an antipsychotic effect but worsens motor function in patients with Parkinson's disease and psychosis.
    Sa DS; Kapur S; Lang AE
    Clin Neuropharmacol; 2001; 24(4):242-4. PubMed ID: 11479398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study.
    Guo MY; Etminan M; Procyshyn RM; Kim DD; Samii A; Kezouh A; Carleton BC
    J Clin Psychopharmacol; 2018 Aug; 38(4):349-356. PubMed ID: 29901567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant Treatment with Venlafaxine and Mirtazapine: no Effect on Serum Concentration of Vascular Endothelial Growth Factor (VEGF).
    Deuschle M; Gilles M; Scharnholz B; Kahl KG
    Pharmacopsychiatry; 2015 Nov; 48(7):292-3. PubMed ID: 26190286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression.
    Fawcett J; Barkin RL
    J Affect Disord; 1998 Dec; 51(3):267-85. PubMed ID: 10333982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.